A new chlorinated metabolite designated chlokamycin (1), was isolated along with ikarugamycin (2) from the culture broth of the marine-derived Streptomyces sp. MA2-12. The structure of 1 was elucidated based on spectroscopic analyses (1D and 2D NMR data and ROESY correlations). Chlokamycin moderately inhibited the growth of Jurkat cells and HCT116 cells with IC 50 values of 24.7 and 33.5 M, respectively.
In the course of our search for new drug seeds, we have identified a number of bioactive compounds, such as inhibitors of neutral lipid accumulation as well as anticancer, antimicrobial, and antifungal agents from microorganisms [1] [2] [3] [4] . Our group has recently focused on the isolation of a number of microorganisms from various environments in Japan, including subtropical small island, marine, and hot spring environments. Marine-derived microorganisms are richly diverse; therefore, they are suitable sources for new bioactive product discovery. The strain Streptomyces sp. MA2-12 was isolated by the Marine Biosciences Kamaishi Research Laboratory as one of the marine Actinomycetes. A new chloride metabolite named chlokamycin (1) was isolated from the broth of this strain cultured in seawater-containing medium along with structurally related ikarugamycin (2) [5] .
Chlokamycin (1) was obtained as a dark green solid. Its molecular formula was established as C 30 H 41 N 2 O 7 Cl ([M+H] + m/z 577.2681, calcd [M+H] + 577.2686) based on high-resolution ESI-MS measurements, indicating that 1 contained 11 degrees of unsaturation. The ratio of M to M+2 peaks on MS data was 3 to 1, indicating that 1 had one chloride atom in its structure. The IR spectrum of 1 showed characteristic absorption at 3379 and 1701 cm -1 , suggesting the presence of hydroxyl and carbonyl moieties. Compound 1 showed absorption maxima at 236 and 320 nm in the UV spectrum.
The structure of 1 was mainly elucidated by an analysis of NMR spectra including 2D NMR in comparison with those of known ikarugamycin (2) . 1 H and 13 C NMR data (in DMSO-d 6 ) supported the molecular formula ( Table 1) . The 13 C NMR spectrum showed 30 resolved signals, which were classified into three methyl carbons including one methoxy carbon, five methylene carbons, 17 methine carbons including four sp 2 methine carbons, and five quaternary carbons. The 1 H NMR spectrum of 1 showed two doublet methyl signals, one methoxy signal, some methylene and methine signals, and five exchangeable proton signals. The connectivity of all proton and carbon atoms was established by HMQC experiments (Table 1 ). An analysis of 1 H-1 H COSY data revealed partial structures I and II (Figure 2 ). An analysis of HMBC spectroscopic data gave the following structural information; 1) Cross peaks from H-2 (3.87 to C-1 (193.1 and C-27 (175.5 and from 28-NH to C-1 supported partial structure I. 2) Cross peaks from H-23 (6.66) and H-24 (6.86 to C-25 (171.7 and from H 3 -32 (3.16 to C-30 (76.2 supported partial structure II. 3) Cross peaks from 28-NH and H-24 to C-26 (100.5and from H 2 -5 (3.27, 2.58and H-8 (5.73 to C-7 (165.6indicated that partial structures I and II were connected at the two ends via C-26 and C-7, as shown in Figure 2 left. In addition, the hydroxyl group-bearing positions were elucidated from chemical shifts in 13 C-NMR experiments, which were C-1, C-3 (70.4 and C-13 (66.1. All hydroxyl group signals were observed as a broad signal around 5. ) . In addition, one acetyl methyl signal (2.30) was broad. These results support the hydroxyl group-bearing positions being C-1, C-3 and C-13. We concluded that a chloride atom needs to be attached to C-14 (71.8 from the molecular formula. Based on the results obtained, the planar structure of 1 was elucidated as shown in Figure 1 . The carbon skeleton of 1 contained 13 stereogenic centers. Relative stereochemistry was elucidated by NOE correlations (Figure 2 ) in comparison with the data of 2. Regarding partial structure I, the correlation between 2-H and 3-H indicated that these protons were located on the same side (2S * , 3S * ). The stereochemistry of partial structure II was elucidated in a similar manner. The correlation between 10-H 2 and 22-H indicated 11S * and 22 S * . The correlation between 10-H 2 and 13-H and between 13-H and 14-H suggested that the protons were located on the same side (13R * , 14S * ). Furthermore, the correlations between 14-H and 15-H and 31-H 3 , between 30-H and 15-H and 29-H 3 , and between 17-H and 19-H indicated that these pairs of protons were located on the same side (15R * , 16R * , 17R * , and 19R * ). It was not possible to elucidate the stereochemistries of C-12 and C-20 because both proton signals overlapped and the stereochemistry of C-30 was difficult to elucidate from NOE correlations (Figure 2) . Thus, some of the relative stereochemistries in parts of partial structures I and II were elucidated independently. The double bonds between C-8 and C-9 and between C-23 and C24 were found to be Z and E from the coupling constants (11.0 and 15.0 Hz), respectively (Table 1) . X-ray crystallography will be effective for elucidating the total absolute stereochemistry of 1 because that of 2 was achieved using this method [5] .
NPC Natural Product Communications
The biological activities of 1 and 2 were investigated using our inhouse assay systems. Since 2 was previously reported to be an anticancer agent [6] , the cytotoxic activities of 1 and 2 in Jurkat cells (a T-cell leukemia-derived cell line) at 20 h were measured using the MTT assay [7] . Compounds 1 and 2 showed dosedependent cytotoxic effects with IC 50 values of 24.7 and 2.16 M, respectively. Furthermore, compound 1 exhibited cytotoxicity against HCT116 (human colon carcinoma) cells with an IC 50 value of 33.5 M. Antimicrobial activities against methicillin-resistant Staphylococcus aureus K-24, Candida albicans ATCC90029, and Aspergillus fumigatus NBRC33022 were not observed by the micro-dilution method (MIC, > 100 M) [8] [9] [10] .
Compounds 1 and 2 shared the common structural characteristics of polycyclic tetramic acid macrolactams (PTM) with capsimycin (3) [11] , butremycin (4) [12] , and isoikarugamycin (5) [13] (Figure 3 ). Capsimycin (3) was isolated from Streptomyces sp. C49-87 as an antifungal agent in 1979 [11] . Since 3 has an epoxide moiety between C-13 and C-14, 1 may be an artifact from 3-hydroxyl capsimycin during the isolation process. In order to rule out this possibility, culture broths of strain MA2-12 from days 1 to 7 were directly analyzed by HPLC. As a result, 1 was detected on day 3, and its production level increased until day 7 (2.3 g/mL). Thus, we concluded that chlokamycin was a microbial metabolite. Butremycin (4) was isolated from marine-derived Micromonospora sp. K310 in 2014 [12] and isoikarugamycin (5) was isolated from marine-derived Streptomyces zhaozhouensis in 2015 [13] . These findings showed that marine microorganisms have potential in the production of new congeners of well-known microbial products. 
Experimental
General: ESI-MS spectrometry was conducted on a JMS-T100LP spectrometer (JEOL, Tokyo, Japan). UV and IR spectra were measured with a U-2800 spectrophotometer (HITACHI, Tokyo, Japan) and FT/IR-460 plus spectrometer (JASCO, Tokyo, Japan), respectively. Optical rotations were recorded with a JASCO P-2200 polarimeter (JASCO, Tokyo, Japan). NMR spectra were recorded on an INOVA 600 spectrometer (Agilent Technologies Inc., Santa Clara, California, USA). Reversed-phase HPLC separations were performed using a PEGASIL ODS SP100 preparative ODS column (20 x 250 mm, Senshu Scientific Co., Tokyo, Japan) at a flow rate of 8 ml min -1 using a SHIMADZU LS20AT pump and SHIMAZU LS20AS UV detector (SHIMADZU, Kyoto, Japan). Absorbance was read with Power Wave 340 (BIO-TEK INSTRUMENTS INC, Winooski, VT, USA). 
MTT Analysis:
The cytotoxic activities of compounds against Jurkat cells and HCT116 cells were evaluated using the MTT assay, as described previously [7] . In brief, Jurkat cells (5.0 x 10 5 cells in 100 L) in a 96-well microplate were treated with samples (0 to 100 M) at 37°C for 20 h. After being incubated, cells were treated with 10 L MTT solution (5.5 mg mL -1 in phosphate-buffered saline), and were then incubated at 37˚C for 4 h. A 90-L aliquot of lysis solution (40% N, N-dimethylformamide, 2.0% CH 3 COOH, 20% SDS, and 0.03 M HCl) was added to each well, and the plates were incubated for 2 h. The absorbance of each well at 570 nm was read with Power Wave 340. The inhibition of cell growth was defined as {1 -(absorbance of the sample/absorbance of the control)} x 100. The IC 50 value was defined as a sample concentration that inhibits cell growth by 50%.
Identification of strain MA2-12: Strain MA2-12 was isolated by the Marine Biosciences Kamaishi Research laboratory as one of the marine Actinomycetes. Strain MA2-12 was cultured on ISP2 medium made for identification, followed by DNA extraction, PCR, sequencing, and Basic Local Alignment Search Tool (BLAST) searching. The primer set 16S-10F (5'-GTTTGATCCTGGCTCA-3') and 16S-800R (5'-TACCAGGGTATCTAATCC-3') was used to amplify the region under the conditions of 25 cycles at 96°C for 30 seconds, 50°C for 15 seconds, and 60°C for 4 min. This sequence is available at the National Center for Biotechnology Information (US). Based on the BLAST search and its microscopic features, the strain was identified as Streptomyces sp.
Fermentation:
The strain was inoculated into a 300-mL Erlenmeyer flask containing 50 mL seed medium (1.0% soluble starch, 0.4% yeast extract, and 2% peptone). The flask was shaken on a rotary shaker at 27°C for 3 days. The seed culture (1.0 mL) was transferred into a 500-mL Erlenmeyer flask containing 100 ml production medium (1.0% soluble starch, 0.004% Fe 2 (SO 4 )•nH 2 O, 0.4% yeast extract, 2% peptone, 0.1% CaCO 3 , 0.01% KBr, and natural seawater (Shojikido (Shizuoka, Japan)). Fermentation was performed at 27˚C for 8 days under shaking conditions (180 rpm).
Isolation of chlokamycin (1) and ikarugamycin (2):
The culture broth (100 mL x 60) was extracted with ethanol (6.0 L) for two hours. After this extract was concentrated to remove ethanol, the aqueous solution was extracted with EtOAc under the pH3.0 condition, yielding the crude extract (1.4 g) after evaporation of the EtOAc fraction. The crude extract was dissolved in a small volume of chloroform, applied to a silica gel column (35 g, 35 x 95 mm), and eluted stepwise with 25:1, 10:1, 5:1, and 1:1 (v/v) of chloroform-methanol solvent and 100% methanol (200 mL each). Crude 1 was obtained in the fraction eluted with 100% methanol. This fraction was further purified by reversed-phase C-4 HPLC under the following conditions: column, 20 x 250 mm, Senshu Pak PEGASIL C 4 (Senshu Scientific Co., Tokyo, Japan); solvent, 45% aqueous acetonitrile with 0.05% TFA; at a flow rate of 8.0 mL min -1 ; UV detection at 210 nm. Chlokamycin (1) was eluted as a peak with a retention time of 17.7 min. This peak was collected and concentrated to yield 1 (7.8 mg) as a dark green solid. Crude 2 was obtained in the fraction eluted with the 10:1 chloroform-methanol eluted fraction. This fraction was further purified by reversed-phase C-4 HPLC under the following conditions: column, 20 x 250 mm, Senshu Pak PEGASIL C 4 ; solvent, 30-min linear gradient from 50 to 80% aqueous acetonitrile with 0.05% trifluoroacetic acid (TFA); at a flow rate of 8.0 mL min -1 ; UV detection at 210 nm. Compound 2 was eluted as a peak with a retention time of 29.9 min. This peak was collected and concentrated to yield 2 (6.0 mg) as an orange solid.
Acetylation of chlokamycin (1) and purification of tri-acetylated 1: Chlokamycin (1) (2.0 mg) was dissolved in dry pyridine (250 L) and acetic anhydride (250 L) was added at 60˚C for 6 h. The reaction mixture was evaporated in vacuo to obtain the products (2.1 mg). The products were purified by reversed-phase C-18 HPLC (4.6 x 250 mm, PEGASIL ODS P100 (Senshu Scientific Co., Tokyo, Japan), with the solvent 85% acetonitrile in 0.05% TFA, and at a flow rate of 1.0 mL min -1 with UV detection at 210 nm. Under these conditions, the derivative was eluted as a peak with a retention time of 13.8 min. This peak was collected and concentrated to yield 1.8 mg as a pale yellow solid. 
